List view / Grid view
4 May 2012 | By Pfizer
Pfizer announced that a Phase 3 randomized withdrawal design study for Lyrica in patients...
3 May 2012 | By Alto Marketing
Population Genetics Technologies Ltd., has appointed Alan Schafer, PhD to the post of Chief Executive Officer...
3 May 2012 | By Gerresheimer
Gerresheimer will be displaying its comprehensive range of prefillable syringe systems at Booth K701 of the Korea Pack...
3 May 2012 | By Sanofi
FDA and the EMA approve 2nd operation for filling and finishing product...
3 May 2012 | By Roche
Roche announced that the SUMMACTA study met its primary endpoint...
3 May 2012 | By Abbott
Abbott plans to establish its first nutrition R&D center with Syngene...
3 May 2012 | By GlaxoSmithKline
GlaxoSmithKline plc announces that Ms. Lynn Elsenhans and Ms. Jing Ulrich will join the Board...
2 May 2012 | By Novartis
Definitive agreement to acquire Fougera Pharmaceuticals for USD 1.525 billion in an all-cash transaction...
2 May 2012 | By Novo Nordisk
Novo Nordisk A/S has entered into an agreement to purchase 5,100,000 B shares...
2 May 2012 | By H. Lundbeck A/S
H. Lundbeck A/S reports first quarter revenue of DKK 3,442 million...
2 May 2012 | By Syrris
Syrris is building on the success of its previous flow chemistry and automated process chemistry seminars...
2 May 2012 | By Citigate Dewe Rogerson
Dr Esteban Pombo-Villar appointed as COO of the OBT group...
1 May 2012 | By Novartis
Results from two-year CATT...
1 May 2012 | By GlaxoSmithKline
GSK and Yale University have established a drug discovery research collaboration...
1 May 2012 | By Catalent Pharma Solutions
Carolyn Finkle at Catalent to present webinar...
